Thalidomide Manufacturer Apologizes for Birth Defects 50 Years Later
The CEO of the Gurenthal Group apologized for manufacturing an anti-morning sickness pill that led to thousands of birth defects
The German manufacturer of the anti-morning sickness pill thalidomide — blamed for causing birth defects in thousands of babies — has issued its first ever apology, 50 years after pulling the drug off the market. But victims say an apology is not enough.
"We ask for forgiveness that for nearly 50 years we didn't find a way of reaching out to you from human being to human being," said Harald Stock, chief executive of Grunenthal Group, on Friday. "We ask that you regard our long silence as a sign of the shock that your fate caused in us."
Editor's Note: As of February 29, 2024, commenting privileges on reason.com posts are limited to Reason Plus subscribers. Past commenters are grandfathered in for a temporary period. Subscribe here to preserve your ability to comment. Your Reason Plus subscription also gives you an ad-free version of reason.com, along with full access to the digital edition and archives of Reason magazine. We request that comments be civil and on-topic. We do not moderate or assume any responsibility for comments, which are owned by the readers who post them. Comments do not represent the views of reason.com or Reason Foundation. We reserve the right to delete any comment and ban commenters for any reason at any time. Comments may only be edited within 5 minutes of posting. Report abuses.
Please
to post comments
Better late than never!
I give this apology three thumbs up!
Better late than never!
Isn't thalidomide still used to treat leprosy?
It's not used to treat leprosy itself, rather a complication of leprosy. Antibiotics from the immune system that are trying to go after the leprosy can start attacking fat tissue instead. It's called erythema nodosum, and that's what thalidomide can help relieve.
It's also being investigated as a treatment for certain types of cancers and multiple myeloma.